[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367810-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367810-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-conserved-fabp5high-macrophage-subset-promotes-fibrosis-and-carcinogenesis-in-advanced-liver-disease","A Conserved FABP5high Macrophage Subset Promotes Fibrosis and Carcinogenesis in Advanced Liver Disease","","Chronic liver disease and liver cancer are linked in ways that remain poorly explained, with few effective options for advanced disease. This study characterizes the dynamic cellular and molecular changes spanning normal liver, cirrhotic tissue, primary liver cancer, and paired adjacent samples. Single-cell RNA sequencing defines a large human liver landscape and maps inter- and intra-tumour heterogeneity, while bioinformatics and molecular validations identify conserved FABP5high macrophage biology and pathways driving fibrotic and carcinogenic progression, including pro-carcinoma niche formation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-conserved-fabp5high-macrophage-subset-promotes-fibrosis-and-carcinogenesis-in-advanced-liver-disease/367810/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-conserved-fabp5high-macrophage-subset-promotes-fibrosis-and-carcinogenesis-in-advanced-liver-disease/367810.png","ImageObject",300,407,{"name":42,"@type":43},"Elsa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main research goal of this study?","Question",{"text":63,"@type":64},"To elucidate the dynamic evolution of cellular and molecular alterations from normal liver to diseased liver and to clarify mechanisms connecting chronic liver disease with liver cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the cellular heterogeneity analyzed?",{"text":68,"@type":64},"Single-cell RNA sequencing was used to construct a human liver landscape and assess both inter- and intra-tumour heterogeneity, supported by bioinformatics and molecular biology validations.",{"name":70,"@type":61,"acceptedAnswer":71},"What key cell subset drives fibrosis and carcinogenesis?",{"text":72,"@type":64},"A conserved FABP5high macrophage subset shows a dual pro-fibrosis and procarcinogenesis role across progression of liver fibrosis and carcinogenesis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367810,1790687726,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Liver International  \nORIGINAL ARTICLE  OPEN ACCESS   \nA Conserved FABP5high Macrophage Subset Promotes Fibrosis and Carcinogenesis in Advanced Liver Disease  \nWenhao Ge1,2 | Lifeng Ma3,4 | Yu Huang1,2 | Weigao E3,4 | Shujing Lai5 | Bijun Cui2 | Jingjing Wang3,4 | Yutian Ji1,2 | Daiyuan Liu3,4 | Song Ye1 | Yang Kong1 | Jiarong Zhou1,2 | Chengxuan Yu6 | Yingsheng Wu1 | Qiang Sun1 | Dongkai Zhou1 | Wei Zhu2 | Yuan Ding1,2,7,8,9,10 | Xiaoping Han3,4 | Guoji Guo3,4 | Weilin Wang1,2,7,8,9,10   \n1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China | 2Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China | 3Bone Marrow Transplantation Center of the First Affiliated Hospital, and Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China | 4Liangzhu Laboratory, Zhejiang University, Hangzhou, China | 5Department of Immunology and Microbiology, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China | 6Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China | 7Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, China | 8National Innovation Center for Fundamental Research on Cancer Medicine, Hangzhou, China | 9Cancer Center, Zhejiang University, Hangzhou, China | 10ZJU-Pujian Research & Development Center of Medical Artificial Intelligence for Hepatobiliary and Pancreatic Disease, Hangzhou, China  \nCorrespondence: Xiaoping Han ([xhan@zju.edu.cn](xhan@zju.edu.cn)) | Guoji Guo ([ggj@zju.edu.cn](ggj@zju.edu.cn)) | Weilin Wang ([wam@zju.edu.cn](wam@zju.edu.cn))  \nReceived: 5 November 2024 | Revised: 14 July 2025 | Accepted: 24 July 2025  \nHandling Editor: Luca Valenti  \nFunding: This work was supported by National Natural Science Foundation of China, 82072650, 32100730, 81802844; Zhejiang University Basic Research Fund, 226-2022-00037; Key Research and Development Program of Zhejiang Province, 2021C03121 .  \nKeywords: FABP5 | immune cell | liver cancer | tumour microenvironment  \nABSTRACT  \nBackground and Aims: The relationship between chronic liver disease and liver cancer remains poorly understood, and treatment options for advanced liver disease remain limited. This study aims to elucidate the dynamic evolution of cellular and molecular alterations from normal liver to diseased liver.  \nMethods: Single-cell RNA sequencing was performed to profile the dynamic cellular variations from normal liver to diseased liver. Bioinformatics analyses were employed to assess tumour heterogeneity and the evolution of tumour microenvironment. Molecular biology validations were performed to investigate the findings.  \nResults: Through single-cell RNA sequencing, we constructed a human liver landscape consisting of more than 130 000 single cells, from normal, cirrhotic tissue, primary liver cancer and paired adjacent tissues. We profiled both inter-and intra-tumour heterogeneity of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. A dual role of the pro-fibrosis and procarcinogenesis FABP5high macrophage subset was shown to be conserved throughout the progression of liver fibrosis and carcinogenesis; markers, spatial localization, origin, and functional pathways associated with FABP5high macrophages were identified  \n\n| Abbreviations: CNV, copy number variation; CSC, cancer stem cell; DC, dendritic cell; EC, endothelial cell; GO, gene ontology; HCC, hepatocellular carcinoma; HSC, hepatic stellate cell; ICC, intrahepatic cholangiocarcinoma; LSEC, liver sinusoidal endothelial cell; MDSC,","cbCaifOjymMAG64P","https://ap.wps.com/l/cbCaifOjymMAG64P","pdf",11231335,15,"English","# Introduction\n# Methods\n## Single-cell RNA sequencing\n## Bioinformatics and molecular validation\n# Results\n## Cellular landscape and heterogeneity\n## Conserved FABP5high macrophage subset\n## Endothelial subset and EMT-related signaling\n# Conclusions","[{\"question\":\"What is the main research goal of this study?\",\"answer\":\"To elucidate the dynamic evolution of cellular and molecular alterations from normal liver to diseased liver and to clarify mechanisms connecting chronic liver disease with liver cancer.\"},{\"question\":\"How was the cellular heterogeneity analyzed?\",\"answer\":\"Single-cell RNA sequencing was used to construct a human liver landscape and assess both inter- and intra-tumour heterogeneity, supported by bioinformatics and molecular biology validations.\"},{\"question\":\"What key cell subset drives fibrosis and carcinogenesis?\",\"answer\":\"A conserved FABP5high macrophage subset shows a dual pro-fibrosis and procarcinogenesis role across progression of liver fibrosis and carcinogenesis.\"}]","A Conserved FABP5high Macrophage Subset Promotes Fibrosis and Carcinogenesis in Advanced Liver Disease | PDF",1790172787,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b8abd2f168740f5b7bbfbcd6e84649d.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44d23768bd2b9de1486008b8ed4eccf1.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6c34d589deb67e55f7c52c50e4c6e8c.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/441921cac52d61b0b8580853d8645e41.webp",980,1287]